We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Judge Allows Expert Opinion On ACA Impact On Class Status, Decertifies Class

Mealey's (July 6, 2015, 2:12 PM EDT) -- PHILADELPHIA — An expert may opine regarding, among other things, how Patient Protection and Affordable Care Act (ACA) medical loss ratio (MLR) regulations affect class ascertainability, a federal judge held June 30 in decertifying a class of indirect purchasers of Wellbutrin XL (In re: Wellbutrin XL Antitrust Litigation, No. 08-2433, E.D. Pa.; 2015 U.S. Dist. LEXIS 84444).

(Opinion available. Document #93-150722-002Z.)

Direct and indirect purchasers sued the manufacturers of Wellbutrin XL - Biovail Corp., Biovail Laboratories and Biovail Laboratories International (collectively Biovail) - and the drug's...
To view the full article, register now.